Share on StockTwits

Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating restated by research analysts at FinnCap in a report released on Wednesday.

A number of other firms have also recently commented on VEC. Analysts at Nplus1 Brewin reiterated a “hold” rating on shares of Vectura Group PLC in a research note on Friday, May 9th. They now have a GBX 142 ($2.39) price target on the stock. Separately, analysts at N+1 Singer reiterated a “hold” rating on shares of Vectura Group PLC in a research note on Friday, May 9th. They now have a GBX 142 ($2.39) price target on the stock. Finally, analysts at Investec downgraded shares of Vectura Group PLC to a “hold” rating in a research note on Wednesday, April 9th. They now have a GBX 170 ($2.86) price target on the stock. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of GBX 161.25 ($2.71).

Shares of Vectura Group PLC (LON:VEC) traded up 2.16% on Wednesday, hitting GBX 130.25. The stock had a trading volume of 357,981 shares. Vectura Group PLC has a one year low of GBX 76.00 and a one year high of GBX 171.50. The stock has a 50-day moving average of GBX 136.9 and a 200-day moving average of GBX 139.8. The company’s market cap is £441.8 million.

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.